Anzeige
Mehr »
Login
Donnerstag, 19.12.2024 Börsentäglich über 12.000 News von 680 internationalen Medien
Megachance: Aktien-Geheimtipp aus der 2. Reihe - der Markt schläft nicht!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A401UY | ISIN: US36151G6008 | Ticker-Symbol: 12Q0
Lang & Schwarz
18.12.24
07:00 Uhr
1,475 Euro
0,000
0,00 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
INTELLIGENT BIO SOLUTIONS INC Chart 1 Jahr
5-Tage-Chart
INTELLIGENT BIO SOLUTIONS INC 5-Tage-Chart
RealtimeGeldBriefZeit
1,4601,49018.12.

Aktuelle News zur INTELLIGENT BIO SOLUTIONS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiINTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report-
MiIntelligent Bio Gains on Applying for Fingerprinting Review1
MiIntelligent Bio Solutions, Inc.: Intelligent Bio Solutions Announces 510(k) Submission to US FDA for Fingerprint Sweat-Based Drug Screening Technology61NEW YORK, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing...
► Artikel lesen
04.12.Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions to Host Virtual Fireside Chat on Wednesday, December 11th at 4:30 p.m. ET5
03.12.INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report2
26.11.Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Achieves 94.1% Accuracy in Method Comparison Study, Following Positive PK Study Results144Intelligent Fingerprinting Drug Screening System on path to FDA 510(k) submission, expected in the fourth calendar quarter of 2024 INBS will include data from recent PK study alongside results of...
► Artikel lesen
INTELLIGENT BIO SOLUTIONS Aktie jetzt für 0€ handeln
20.11.INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report1
18.11.INBS Stock Declines Despite Positive Results of Pharmacokinetic Study3
13.11.INBS advances in drug detection with fingerprint technology3
07.11.INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report1
07.11.Intelligent Bio Solutions GAAP EPS of -$0.70, revenue of $0.87M5
07.11.INTELLIGENT BIO SOLUTIONS INC. - 10-Q, Quarterly Report2
31.10.Intelligent Bio Solutions partners with B2i Digital for marketing push5
31.10.Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Partners with B2i Digital to Amplify Investor Outreach255NEW YORK, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing...
► Artikel lesen
29.10.INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report3
29.10.Intelligent Bio Solutions sees Q1 revenue of $0.87M3
29.10.Intelligent Bio Solutions reports revenue growth and strategic expansion2
29.10.Intelligent Bio Solutions verzeichnet Umsatzwachstum und strategische Expansion3
29.10.Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Announces Preliminary Unaudited Fiscal 2025 First Quarter Revenue Results177Unaudited quarterly revenue increased 10% year-on-year and 20% quarter-on-quarter Higher-margin, recurring cartridge revenue expected to surpass reader revenue as primary driver ...
► Artikel lesen
16.10.Intelligent Bio Solutions to Present at the LD Micro Main Event XVII on October 28-30 in Los Angeles278New York, New York--(Newsfile Corp. - October 16, 2024) - Intelligent Bio Solutions Inc. (NASDAQ: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive...
► Artikel lesen
Seite:  Weiter >>
74 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1